Patient info Open main menu

Myclausen - patient leaflet, side effects, dosage

Contains active substance :

Dostupné balení:

Patient leaflet - Myclausen

- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

  • 1. What Myclausen is and what it is used for

  • 2. What you need to know before you take Myclausen

  • 3. How to take Myclausen

  • 4. Possible side effects

  • 5. How to store Myclausen

  • 6. Contents of the pack and other information

1. What Myclausen is and what it is used for

The full name of your medicine is Myclausen 500 mg film-coated tablets.

In this leaflet the shorter name Myclausen is used.

Myclausen contains mycophenolate mofetil.

  • This belongs to a group of medicines called “immunosuppres­sants”.

Myclausen is used to prevent your body rejecting a transplanted organ.

  • A kidney, heart or liver.

Myclausen should be used together with other medicines:

  • Ciclosporin and corticosteroids.

2. What you need to know before you take Myclausen

WARNING

Mycophenolate causes birth defects and miscarriage. If you are a woman who could become pregnant, you must provide a negative pregnancy test before starting treatment and must follow the contraception advice given to you by your doctor.

Your doctor will speak to you and give you written information, particularly on the effects of mycophenolate on unborn babies. Read the information carefully and follow the instructions. If you do not fully understand these instructions, please ask your doctor to explain them again before you take mycophenolate. See also further information in this section under “Warnings and precautions” and “Pregnancy and breast-feeding”.

Do not take Myclausen

  • If you are allergic (hypersensitive) to mycophenolate mofetil, mycophenolic acid or any of the

other ingredients of this medicine (listed in section 6).

  • If you are a woman who could be pregnant and you have not provided a negative pregnancy test before your first prescription, as mycophenolate causes birth defects and miscarriage.
  • If you are pregnant or planning to become pregnant or think you may be pregnant
  • If you are not using effective contraception (see Pregnancy, contraception and breast-feeding).

If you are breast-feeding.

Do not take this medicine if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking Myclausen.

Warnings and precautions

Talk to your doctor straight away before starting treatment with Myclausen

  • If you have a sign of infection such as a fever or sore throat
  • If you have any unexpected bruising or bleeding
  • If you have ever had a problem with your digestive system such as a stomach ulcer
  • If you are planning to become pregnant or if you get pregnant while you or your partner are taking Myclausen.

If any of the above apply to you (or you are not sure), talk to your doctor straight away before starting treatment with Myclausen.

The effect of sunlight

Myclausen reduces your body’s defences. As a result, there is an increased risk of skin cancer. Limit the amount of sunlight and UV light you get. Do this by:

  • wearing protective clothing that also covers your head, neck, arms and legs
  • using a sunscreen with a high protection factor.

Other medicines and Myclausen

Please tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription, including herbal medicines. This is because Myclausen can affect the way some other medicines work. Also other medicines can affect the way Myclausen works.

In particular, tell your doctor or pharmacist if you are taking any of the following medicines before you start Myclausen:

  • azathioprine or other medicines that suppress your immune system (given after a transplant operation)
  • cholestyramine (used to treat high cholesterol)
  • rifampicin (an antibiotic used to prevent and treat infections such as tuberculosis (TB))
  • antacids or proton pump inhibitors (used for acid problems in your stomach such as indigestion)
  • phosphate binders (used by people with chronic kidney failure to reduce how much phosphate gets absorbed into their blood).
  • antibiotics (used to treat bacterial infections)
  • isavuconazole (used to treat fungal infections)
  • telmisartan (used to treat high blood pressure)

Vaccines

If you need to have a vaccine (a live vaccine) while taking Myclausen, talk to your doctor or pharmacist first. Your doctor will have to advise you on what vaccines you can have.

You must not donate blood during treatment with Myclausen and for at least 6 weeks after stopping treatment. Men must not donate semen during treatment with Myclausen and for at least 90 days after stopping treatment.

Myclausen with food and drink

Taking food and drink has no effect on your treatment with Myclausen.

Pregnancy, contraception and breast-feeding

Contraception in women taking Myclausen

If you are a woman who could become pregnant you must use an effective method of contraception with Myclausen. This includes:

  • Before you start taking Myclausen
  • During your entire treatment with Myclausen
  • For 6 weeks after you stop taking Myclausen.

Talk to your doctor about the most suitable contraception for you. This will depend on your individual situation. Two forms of contraception are preferable as this will reduce the risk of unintended pregnancy. Contact your doctor as soon as possible, if you think your contraception may not have been effective or if you have forgotten to take your contraceptive pill.

You are a woman who is not capable of becoming pregnant if any of the following applies to you:

  • You are post-menopausal, i.e. at least 50 years old and your last period was more than a year

ago (if your periods have stopped because you have had treatment for cancer, then there is still a chance you could become pregnant)

  • Your fallopian tubes and both ovaries have been removed by surgery (bilateral salpingo-oophorectomy)
  • Your womb (uterus) has been removed by surgery (hysterectomy)
  • Your ovaries no longer work (premature ovarian failure, which has been confirmed by a specialist gynaecologist)
  • You were born with one of the following rare conditions that make pregnancy impossible: the XY genotype, Turner’s syndrome or uterine agenesis
  • You are a child or teenager who has not started having periods.

Contraception in men taking Myclausen

The available evidence does not indicate an increased risk of malformations or miscarriage if the father takes mycophenolate. However, a risk cannot be completely excluded. As a precautionyou or your female partner are recommended to use reliable contraception during treatment and for 90 days after you stop taking Myclausen.

If you are planning to have a child, talk to your doctor about the potential risks and alternative therapies.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Your doctor will talk to you about the risks in case of pregnancy and the alternatives you can take to prevent rejection of your transplant organ if:

  • You plan to become pregnant.
  • You miss or think you have missed a period, or you have unusual menstrual bleeding, or suspect you are pregnant.
  • You have sex without using an effective method of contraception.

If you do become pregnant during the treatment with mycophenolate, you must inform your doctor immediately. However, keep taking Myclausen until you see him or her.

Pregnancy

Mycophenolate causes a very high frequency of miscarriage (50%) and of severe birth defects (23 –27%) in the unborn baby. Birth defects which have been reported include anomalies of ears, of eyes, of face (cleft lip/palate), of development of fingers, of heart, oesophagus (tube that connects the throat with the stomach), kidneys and nervous system (for example spina bifida (where the bones of the spine are not properly developed).Your baby may be affected by one or more of these.

If you are a woman who could become pregnant, you must provide a negative pregnancy test before starting treatment and must follow the contraception advice given to you by your doctor. Your doctor may request more than one test to ensure you are not pregnant before starting treatment.

Breast-feeding

Do not take Myclausen if you are breast-feeding. This is because small amounts of the medicine can pass into the mother’s milk.

Driving and using machines

Myclausen has a moderate influence on your ability to drive or use any tools or machines. If you feel drowsy, numb or confused, talk to your doctor or nurse and do not drive or use any tools or machines until you feel better.

Myclausen contains sodium

This medicinal product contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’

3. How to take Myclausen

Always take Myclausen exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

How much to take

The amount you take depends on the type of transplant you have had. The usual doses are shown below. Treatment will continue for as long as you need to prevent you from rejecting your transplant organ.

Kidney transplant

Adults

  • The first dose is given within 3 days of the transplant operation.
  • The daily dose is 4 tablets (2 g of the medicine) taken as 2 separate doses.
  • Take 2 tablets in the morning and then 2 tablets in the evening.

Children aged 2 to 18 years

  • The dose given will vary depending on the size of the child.
  • Your doctor will decide the most appropriate dose based on your child’s height and weight (body surface area – measured as square metres or ‘m2’). The recommended dose is 600 mg per m2 taken twice a day.

Heart transplant

Adults

  • The first dose is given within 5 days of the transplant operation.
  • The daily dose is 6 tablets (3 g of the medicine) taken as 2 separate doses.
  • Take 3 tablets in the morning and then 3 tablets in the evening.

Children

  • There is no information for the use of Myclausen in children with a heart transplant.

Liver transplant

Adults

  • The first dose of oral Myclausen will be given to you at least 4 days after the transplant operation and when you are able to swallow oral medicines.
  • The daily dose is 6 tablets (3 g of the medicine) taken as 2 separate doses.
  • Take 3 tablets in the morning and then 3 tablets in the evening.

Children

  • There is no information for the use of Myclausen in children with a liver transplant.

How to take Myclausen

  • Swallow your tablets whole with a glass of water.
  • Do not break or crush them.

If you take more Myclausen than you should

If you take more Myclausen than you should, talk to a doctor or go to a hospital straight away. Also do this if someone else accidentally takes your medicine. Take the medicine pack with you.

If you forget to take Myclausen

If you forget to take your medicine at any time, take it as soon as you remember. Then continue to take it at the usual times. Do not take a double dose to make up for a missed dose.

If you stop taking Myclausen

Do not stop taking Myclausen unless your doctor tells you to. If you stop your treatment you may increase the chance of rejection of your transplanted organ.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Talk to a doctor straight away if you notice any of the following serious side effects – you may need urgent medical treatment:

  • you have a sign of infection such as a fever or sore throat
  • you have any unexpected bruising or bleeding
  • you have a rash, swelling of your face, lips, tongue or throat, with difficulty breathing – you may be having a serious allergic reaction to the medicine (such as anaphylaxis, angioeodema).

Usual problems

  • Some of the more usual problems are diarrhoea, fewer white cells or red cells in your blood, infection and vomiting. Your doctor will do regular blood tests to check for any changes in the number of your blood cells or signs of infections.

Children may be more likely than adults to have some side effects. These include diarrhoea, infections, fewer white cells and fewer red cells in the blood.

Fighting infections

Myclausen reduces your body’s defences. This is to stop you rejecting your transplant. As a result, your body will not be as good as normal at fighting infections. This means you may catch more infections than usual. This includes infections of the brain, skin, mouth, stomach and gut, lungs and urinary system.

Lymph and skin cancer

As can happen in patients taking this type of medicine (immune-suppressants), a very small number of Myclausen patients have developed cancer of the lymphoid tissues and skin.

General unwanted effects

You may get general side effects affecting your body as a whole. These include serious allergic reactions (such as anaphylaxis, angioeodema), fever, feeling very tired, difficulty sleeping, pains (such as stomach, chest, joint or muscle), headache, flu symptoms and swelling.

Other unwanted effects may include:

Skin problems such as:

  • acne, cold sores, shingles, skin growth, hair loss, rash, itching.

Urinary problems such as:

  • blood in the urine.

Digestive system and mouth problems such as:

  • swelling of the gums and mouth ulcers
  • inflammation of the pancreas, colon or stomach
  • gastrointestinal disorders including bleeding
  • liver disorders
  • diarrhea, constipation, feeling sick (nausea), indigestion, loss of appetite, flatulence.

Nervous system problems such as:

  • feeling dizzy, drowsy or numb
  • tremor, muscle spasms, convulsions
  • feeling anxious or depressed, changes in your mood or thoughts.

Heart and blood vessel problems such as:

  • change in blood pressure, accelerated heartbeat, widening of blood vessels.

Lung problems such as:

  • pneumonia, bronchitis
  • shortness of breath, cough, which can be due to bronchiectasis (a condition in which the lung airways are abnormally dilated) or pulmonary fibrosis (scarring of the lung). Talk to your doctor if you develop a persistent cough or breathlessness
  • fluid on the lungs or inside the chest
  • sinus problems.

Other problems such as:

  • weight loss, gout, high blood sugar, bleeding, bruising.

5. How to store Myclausen

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Myclausen contains

The active substance is mycophenolate mofetil.

Each tablet contains 500 mg mycophenolate mofetil

The other ingredients are:

Tablet core:

Microcrystalline cellulose, povidone (K-30), croscarmellose sodium, magnesium stearate

Tablet coat:

Polyvinyl alcohol (partially hydrolysed), titanium dioxide (E 171) macrogol 3000,talc

What Myclausen looks like and contents of the pack

White round film-coated tablets.

Myclausen 500 mg film-coated tablets are available in PVC-aluminium blisters containing 10 tablets.

Each carton contains either 50 or 150 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Passauer Pharma GmbH

Eiderstedter Weg 3

14129 Berlin

Germany

Manufacturer

Passauer Pharma GmbH

Eiderstedter Weg 3

14129 Berlin

Germany

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

België/Belgiqu­e/Belgien

Passauer Pharma GmbH, Duitsland/Alle­magne/Deutschland

Tél/Tel: +49(0)3074460–12

Lietuva

Passauer Pharma GmbH,

Vokietija

Tel: +49(0)3074460–12

Efc^rapufl

Passauer Pharma GmbH, repviaHHíi

Ten: +49(0)3074460–12

Luxembourg/Lu­xemburg

Passauer Pharma GmbH, Allemagne/Deut­schland Tél/Tel: +49(0)3074460–12

Česká republika

Pharmagen CZ, s.r.o.

Česká republika

Tel: +420 721 137 749

Magyarország

Passauer Pharma GmbH, Németország

Tel: +49(0)3074460–12

Danmark

Passauer Pharma GmbH,

Tyskland

Tlf: +49(0)3074460–12

Malta

Passauer Pharma GmbH, Il-Germanja

Tel: +49(0)3074460–12

Deutschland

Passauer Pharma GmbH, Deutschland

Tel: +49(0)3074460–12

Nederland

Passauer Pharma GmbH, Duitsland

Tel: +49(0)3074460–12

Eesti

Passauer Pharma GmbH, Saksamaa

Tel: +49(0)3074460–12

Norge

Passauer Pharma GmbH, Tyskland

Tlf: +49(0)3074460–12

EMáóa

YAS Pharma L.P.

Aeœp. Knpioiaç 120 & OXoiaç 10 151 25 Mapoúoi,

A0-qva – EXXáSa

Österreich

Passauer Pharma GmbH, Deutschland

Tel: +49(0)3074460–12

T|X: + 30 210–6194190

España

Passauer Pharma GmbH, Alemania

Tel: +49(0)3074460–12

Polska

Passauer Pharma GmbH,

Niemcy

Tel: +49(0)3074460–12

France

Passauer Pharma GmbH,

Allemagne

Tél: +49(0)3074460–12

Portugal

Passauer Pharma GmbH, Alemanha

Tel: +49(0)3074460–12

Hrvatska

Passauer Pharma GmbH,

Njemačka

Tel: +49(0)3074460–12

România

Passauer Pharma GmbH, Germania

Tel: +49(0)3074460–12

Ireland

Passauer Pharma GmbH,

Germany

Tel: +49(0)3074460–12

Ísland

Passauer Pharma GmbH, Pýskaland

Sími: +49(0)3074460–12

Italia

Passauer Pharma GmbH, Germania

Tel: +49(0)3074460–12

Slovenija

Passauer Pharma GmbH,

Nemčija

Tel: +49(0)3074460–12

Slovenská republika

Passauer Pharma GmbH, Nemecko

Tel: +49(0)3074460–12

Suomi/Finland

Passauer Pharma GmbH,

Saksa

Puh/Tel: +49(0)3074460–12

Kùnpoç

ISANGEN PHARMA CYPRUS LTD

Guricon House, Hvœp.évœv E0vœv 48, 2oç &

3oç ôpopoç

6042, AàpvaKa, Kùnpoç

Tq!.: +357–24–638833

Sverige

Passauer Pharma GmbH,

Tyskland

Tel: +49(0)3074460–12

Latvija

Passauer Pharma GmbH,

Väcija

Tel: +49(0)3074460–12

United Kingdom (Northern Ireland)

Passauer Pharma GmbH,

Germany

Tel: +49(0)3074460–12

This leaflet was last revised in {MM/YYYY}

Detailed information on this medicine is available on the European Medicines Agency web site: